Placebo non-response measure in sequential parallel comparison design studies

Author:

Rybin Denis1,Doros Gheorghe12,Pencina Michael J.3,Fava Maurizio4

Affiliation:

1. Department of Biostatistics; Boston University; 801 Massachusetts Avenue Boston 02118 MA U.S.A.

2. Harvard Clinical Research Institute (HCRI); 930 Commonwealth Avenue 3rd floor, Boston 02215 MA U.S.A.

3. Duke Clinical Research Institute (DCRI); Biostatistics and Bioinformatics, Duke University; 2400 Pratt Street Durham 27705 NC U.S.A.

4. Harvard Medical School; Massachusetts General Hospital; 55 Fruit Street, Bulfinch 351 Boston 02114 MA U.S.A.

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference16 articles.

1. The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach;Fava;Psychotherapy and Psychosomatics,2003

2. Optimality, sample size, and power calculations for the sequential parallel comparison design;Ivanova;Statistics in Medicine,2011

3. The placebo response in clinical trials: more questions than answers;Enck;Philosophical Transactions of Royal Society B,2011

4. Fava M Schoenfeld D System and method for reducing the placebo effect in controlled clinical trials 2010 http://www.patentlens.net/patentlens/patent/US_7840419/en/

5. Fava M Schoenfeld D System and method for reducing the placebo effect in controlled clinical trials 2010 http://www.patentlens.net/patentlens/patent/US_7647235/en/

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3